United Laboratories International Holdings (United Laboratories International Holdings) Total Stockholders Equity : $1,784 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings Total Stockholders Equity?

United Laboratories International Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1,784 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. United Laboratories International Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $0.98. The ratio of a company's debt over equity can be used to measure how leveraged this company is. United Laboratories International Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.12.

United Laboratories International Holdings Total Stockholders Equity Historical Data

The historical data trend for United Laboratories International Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Total Stockholders Equity Chart

United Laboratories International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

951.25

1,317.25

1,466.49

1,521.59

1,783.53

United Laboratories International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															1,466.49	1,456.23	1,521.59	1,610.09	1,783.53

United Laboratories International Holdings (OTCPK:ULIHF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

United Laboratories International Holdings's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1783.532	-	0)	/	1817.03
	=	0.98

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

United Laboratories International Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(28.061	+	182.533)	/	1783.532
	=	0.12

United Laboratories International Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings (United Laboratories International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

03933:Hong Kong UNJ:Germany

Address

No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG

Website

http://www.tul.com.cn

United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (United Laboratories International Holdings) Headlines

No Headlines